1. Home
  2. DIN vs PRTC Comparison

DIN vs PRTC Comparison

Compare DIN & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dine Brands Global Inc.

DIN

Dine Brands Global Inc.

HOLD

Current Price

$28.10

Market Cap

446.6M

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$16.33

Market Cap

464.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIN
PRTC
Founded
1958
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
446.6M
464.3M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
DIN
PRTC
Price
$28.10
$16.33
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
380.5K
3.9K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
2.69%
N/A
EPS Growth
N/A
N/A
EPS
1.11
N/A
Revenue
$879,300,000.00
N/A
Revenue This Year
$3.61
N/A
Revenue Next Year
$0.41
N/A
P/E Ratio
$25.40
$8.09
Revenue Growth
8.25
N/A
52 Week Low
$18.63
$13.30
52 Week High
$39.68
$20.00

Technical Indicators

Market Signals
Indicator
DIN
PRTC
Relative Strength Index (RSI) 35.69 40.46
Support Level $27.52 $15.72
Resistance Level $28.64 $18.10
Average True Range (ATR) 1.18 0.54
MACD -0.17 -0.08
Stochastic Oscillator 13.71 12.11

Price Performance

Historical Comparison
DIN
PRTC

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: